» Articles » PMID: 2566368

The Immunophenotype of Reed-Sternberg Cells. A Study of 50 Cases of Hodgkin's Disease Using Fixed Frozen Tissues

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 1989 Jun 1
PMID 2566368
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The authors analyzed 50 cases of Hodgkin's disease (HD) with a panel of antibodies which detect B-cell and T-cell specific markers and activation antigens using a sensitive immunocytochemical technique and paraformaldehyde-lysine-periodate (PLP) fixed-frozen tissues. In 60% of cases either T-cell or B-cell specific antigens were detected on Reed-Sternberg (RS) cells. Most T-cell cases were of nodular sclerosing (NS) and mixed cellularity (MC) type (65% and 30%, respectively) and most B-cell cases were either of NS or lymphocyte predominant (LP) type (55% and 45%, respectively). Leukocyte common antigen (LCA) was usually negative on RS cells in NS, but was present in approximately 50% of the cases of MC and LP types. Almost all cases were positive for the CD30 antigen (Ki-1). Most cases were also positive for CD15 (LeuM1) with the exception of the LP type. Activation antigens (Ia, CD25, T9) were expressed in a high proportion of cases regardless of subtype. The results suggest that most cases of HD are histogenetically derived from activated T-cells or B-cells.

Citing Articles

Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study.

Hamadani M, Collins G, Caimi P, Samaniego F, Spira A, Davies A Lancet Haematol. 2021; 8(6):e433-e445.

PMID: 34048682 PMC: 9241579. DOI: 10.1016/S2352-3026(21)00103-4.


90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.

Janik J, Morris J, OMahony D, Pittaluga S, Jaffe E, Redon C Proc Natl Acad Sci U S A. 2015; 112(42):13045-50.

PMID: 26438866 PMC: 4620907. DOI: 10.1073/pnas.1516107112.


Toxin-based therapeutic approaches.

Shapira A, Benhar I Toxins (Basel). 2011; 2(11):2519-83.

PMID: 22069564 PMC: 3153180. DOI: 10.3390/toxins2112519.


Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism.

Blum K, Jung S, Johnson J, Lin T, Hsi E, Lucas D Ann Oncol. 2010; 21(11):2246-2254.

PMID: 20423913 PMC: 2962257. DOI: 10.1093/annonc/mdq211.


Constitutive overexpression of a novel 21 kDa protein by Hodgkin lymphoma and aggressive non-Hodgkin lymphomas.

Zhou M, Fadlelmola F, Cohn J, Skinnider B, Gascoyne R, Banerjee D Mol Cancer. 2008; 7:12.

PMID: 18218123 PMC: 2267462. DOI: 10.1186/1476-4598-7-12.